Report Content
Chapter 1 Methodology & Scope
1.1 Market definitions
1.2 Base estimates & working
1.3 Forecast parameters
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Corneal Implants industry 360° synopsis, 2017 - 2030
2.1.1 Business trends
2.1.2 Tissue type trends
2.1.3 Transplant type trends
2.1.4 Condition trends
2.1.5 End-use trends
2.1.6 Regional trends
Chapter 3 Corneal Implants Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2017 - 2030
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Increasing incidence of eye diseases worldwide
3.3.1.2 Rising elderly population in developed economies
3.3.1.3 Growing demand for minimally invasive surgical procedure across the globe
3.3.1.4 Increasing technological advancements in corneal implants
3.3.2 Industry pitfalls & challenges
3.3.2.1 Risks associated with corneal implants
3.3.2.2 Shortage of donor material worldwide
3.4 Growth potential analysis
3.4.1 By tissue type
3.4.2 By transplant type
3.4.3 By condition
3.4.4 By end-use
3.5 COVID- 19 impact analysis
3.6 Porter's analysis
3.7 Competitive landscape, 2021
3.8 PESTEL analysis
Chapter 4 Corneal Implants Market, By Tissue Type
4.1 Key segment trends
4.2 Human donor
4.2.1 Market size, by region, 2017 - 2030 (USD Million)
4.3 Artificial cornea
4.3.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 5 Corneal Implants Market, By Transplant Type
5.1 Key segment trends
5.2 Anterior lamellar keratoplasty (ALK)
5.2.1 Market size, by region, 2017 - 2030 (USD Million)
5.3 Endothelial lamellar keratoplasty (ELK)
5.3.1 Market size, by region, 2017 - 2030 (USD Million)
5.4 Penetrating keratoplasty (PK)
5.4.1 Market size, by region, 2017 - 2030 (USD Million)
5.5 Others
5.5.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 6 Corneal ImplantsMarket, By Condition
6.1 Key segment trends
6.2 Fungal keratitis
6.2.1 Market size, by region, 2017 - 2030 (USD Million)
6.3 Fuchs' dystrophy
6.3.1 Market size, by region, 2017 - 2030 (USD Million)
6.4 Keratoconous
6.4.1 Market size, by region, 2017 - 2030 (USD Million)
6.5 Others
6.5.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 7 Corneal ImplantsMarket, By End-use
7.1 Hospitals
7.1.1 Market size, by region, 2017 - 2030 (USD Million)
7.2 Eye clinics
7.2.1 Market size, by region, 2017 - 2030 (USD Million)
7.3 Ambulatory surgical cenetrs
7.3.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 8 Corneal ImplantsMarket, By Region
8.1 Key regional trends
8.2 North America
8.2.1 Market size, by country, 2017 - 2030 (USD Million)
8.2.2 Market size, by tissue type, 2017 - 2030 (USD Million)
8.2.3 Market size, by transplant type, 2017 - 2030 (USD Million)
8.2.4 Market size, by condition, 2017 – 2030 (USD Million)
8.2.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.2.6 U.S.
8.2.6.1 Market size, by tissue type, 2017 - 2030 (USD Million)
8.2.6.2 Market size, by transplant type, 2017 - 2030 (USD Million)
8.2.6.3 Market size, by condition, 2017 – 2030 (USD Million)
8.2.6.4 Market size, by end-use, 2017 – 2030 (USD Million)
8.2.7 Canada
8.2.7.1 Market size, by tissue type, 2017 - 2030 (USD Million)
8.2.7.2 Market size, by transplant type, 2017 - 2030 (USD Million)
8.2.7.3 Market size, by condition, 2017 – 2030 (USD Million)
8.2.7.4 Market size, by end-use, 2017 – 2030 (USD Million)
8.3 Europe
8.3.1 Market size, by country, 2017 - 2030 (USD Million)
8.3.2 Market size, by tissue type, 2017 - 2030 (USD Million)
8.3.3 Market size, by transplant type, 2017 - 2030 (USD Million)
8.3.4 Market size, by condition, 2017 – 2030 (USD Million)
8.3.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.3.6 Germany
8.3.6.1 Market size, by tissue type, 2017 - 2030 (USD Million)
8.3.6.2 Market size, by transplant type, 2017 - 2030 (USD Million)
8.3.6.3 Market size, by condition, 2017 – 2030 (USD Million)
8.3.6.4 Market size, by end-use, 2017 – 2030 (USD Million)
8.3.7 UK
8.3.7.1 Market size, by tissue type, 2017 - 2030 (USD Million)
8.3.7.2 Market size, by transplant type, 2017 - 2030 (USD Million)
8.3.7.3 Market size, by condition, 2017 – 2030 (USD Million)
8.3.7.4 Market size, by end-use, 2017 – 2030 (USD Million)
8.3.8 France
8.3.8.1 Market size, by tissue type, 2017 - 2030 (USD Million)
8.3.8.2 Market size, by transplant type, 2017 - 2030 (USD Million)
8.3.8.3 Market size, by condition, 2017 – 2030 (USD Million)
8.3.8.4 Market size, by end-use, 2017 – 2030 (USD Million)
8.3.9 Italy
8.3.9.1 Market size, by tissue type, 2017 - 2030 (USD Million)
8.3.9.2 Market size, by transplant type, 2017 - 2030 (USD Million)
8.3.9.3 Market size, by condition, 2017 – 2030 (USD Million)
8.3.9.4 Market size, by end-use, 2017 – 2030 (USD Million)
8.3.10 Spain
8.3.10.1 Market size, by tissue type, 2017 - 2030 (USD Million)
8.3.10.2 Market size, by transplant type, 2017 - 2030 (USD Million)
8.3.10.3 Market size, by condition, 2017 – 2030 (USD Million)
8.3.10.4 Market size, by end-use, 2017 – 2030 (USD Million)
8.4 Asia Pacific
8.4.1 Market size, by country, 2017 - 2030 (USD Million)
8.4.2 Market size, by tissue type, 2017 - 2030 (USD Million)
8.4.3 Market size, by transplant type, 2017 - 2030 (USD Million)
8.4.4 Market size, by condition, 2017 – 2030 (USD Million)
8.4.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.4.6 Japan
8.4.6.1 Market size, by tissue type, 2017 - 2030 (USD Million)
8.4.6.2 Market size, by transplant type, 2017 - 2030 (USD Million)
8.4.6.3 Market size, by condition, 2017 – 2030 (USD Million)
8.4.6.4 Market size, by end-use, 2017 – 2030 (USD Million)
8.4.7 China
8.4.7.1 Market size, by tissue type, 2017 - 2030 (USD Million)
8.4.7.2 Market size, by transplant type, 2017 - 2030 (USD Million)
8.4.7.3 Market size, by condition, 2017 – 2030 (USD Million)
8.4.7.4 Market size, by end-use, 2017 – 2030 (USD Million)
8.4.8 India
8.4.8.1 Market size, by tissue type, 2017 - 2030 (USD Million)
8.4.8.2 Market size, by transplant type, 2017 - 2030 (USD Million)
8.4.8.3 Market size, by condition, 2017 – 2030 (USD Million)
8.4.8.4 Market size, by end-use, 2017 – 2030 (USD Million)
8.4.9 South Korea
8.4.9.1 Market size, by tissue type, 2017 - 2030 (USD Million)
8.4.9.2 Market size, by transplant type, 2017 - 2030 (USD Million)
8.4.9.3 Market size, by condition, 2017 – 2030 (USD Million)
8.4.9.4 Market size, by end-use, 2017 – 2030 (USD Million)
8.4.10 Australia
8.4.10.1 Market size, by tissue type, 2017 - 2030 (USD Million)
8.4.10.2 Market size, by transplant type, 2017 - 2030 (USD Million)
8.4.10.3 Market size, by condition, 2017 – 2030 (USD Million)
8.4.10.4 Market size, by end-use, 2017 – 2030 (USD Million)
8.5 Latin America
8.5.1 Market size, by country, 2017 - 2030 (USD Million)
8.5.2 Market size, by tissue type, 2017 - 2030 (USD Million)
8.5.3 Market size, by transplant type, 2017 - 2030 (USD Million)
8.5.4 Market size, by condition, 2017 – 2030 (USD Million)
8.5.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.5.6 Brazil
8.5.6.1 Market size, by tissue type, 2017 - 2030 (USD Million)
8.5.6.2 Market size, by transplant type, 2017 - 2030 (USD Million)
8.5.6.3 Market size, by condition, 2017 – 2030 (USD Million)
8.5.6.4 Market size, by end-use, 2017 – 2030 (USD Million)
8.5.7 Mexico
8.5.7.1 Market size, by tissue type, 2017 - 2030 (USD Million)
8.5.7.2 Market size, by transplant type, 2017 - 2030 (USD Million)
8.5.7.3 Market size, by condition, 2017 – 2030 (USD Million)
8.5.7.4 Market size, by end-use, 2017 – 2030 (USD Million)
8.5.8 Argentina
8.5.8.1 Market size, by tissue type, 2017 - 2030 (USD Million)
8.5.8.2 Market size, by transplant type, 2017 - 2030 (USD Million)
8.5.8.3 Market size, by condition, 2017 – 2030 (USD Million)
8.5.8.4 Market size, by end-use, 2017 – 2030 (USD Million)
8.6 Middle East & Africa
8.6.1 Market size, by country, 2017 - 2030 (USD Million)
8.6.2 Market size, by tissue type, 2017 - 2030 (USD Million)
8.6.3 Market size, by transplant type, 2017 - 2030 (USD Million)
8.6.4 Market size, by condition, 2017 – 2030 (USD Million)
8.6.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.6.6 South Africa
8.6.6.1 Market size, by tissue type, 2017 - 2030 (USD Million)
8.6.6.2 Market size, by transplant type, 2017 - 2030 (USD Million)
8.6.6.3 Market size, by condition, 2017 – 2030 (USD Million)
8.6.6.4 Market size, by end-use, 2017 – 2030 (USD Million)
8.6.7 Saudi Arabia
8.6.7.1 Market size, by tissue type, 2017 - 2030 (USD Million)
8.6.7.2 Market size, by transplant type, 2017 - 2030 (USD Million)
8.6.7.3 Market size, by condition, 2017 – 2030 (USD Million)
8.6.7.4 Market size, by end-use, 2017 – 2030 (USD Million)
8.6.8 UAE
8.6.8.1 Market size, by tissue type, 2017 - 2030 (USD Million)
8.6.8.2 Market size, by transplant type, 2017 - 2030 (USD Million)
8.6.8.3 Market size, by condition, 2017 – 2030 (USD Million)
8.6.8.4 Market size, by end-use, 2017 – 2030 (USD Million)
Chapter 9 Company Profiles
9.1 Strategy dashboard, 2021
9.2 Alabama Eye Bank Inc.
9.2.1 Business overview
9.2.2 Financial data
9.2.3 Product landscape
9.2.4 Strategic outlook
9.2.5 Swot analysis
9.3 Alcon Inc.
9.3.1 Business overview
9.3.2 Financial data
9.3.3 Product landscape
9.3.4 Strategic outlook
9.3.5 Swot analysis
9.4 DIPOTEX
9.4.1 Business overview
9.4.2 Financial data
9.4.3 Product landscape
9.4.4 Strategic outlook
9.4.5 Swot analysis
9.5 Florida Lions Eye Bank
9.5.1 Business overview
9.5.2 Financial data
9.5.3 Product landscape
9.5.4 Strategic outlook
9.5.5 Swot analysis
9.6 Presbia PLC
9.6.1 Business overview
9.6.2 Financial data
9.6.3 Product landscape
9.6.4 Strategic outlook
9.6.5 Swot analysis
9.7 CorneaGen
9.7.1 Business overview
9.7.2 Financial data
9.7.3 Product landscape
9.7.4 Strategic outlook
9.7.5 Swot analysis
9.8 CorNeat Vision Ltd.
9.8.1 Business overview
9.8.2 Financial data
9.8.3 Product landscape
9.8.4 Strategic outlook
9.8.5 Swot analysis
9.9 Aurolab
9.9.1 Business overview
9.9.2 Financial data
9.9.3 Product landscape
9.9.4 Strategic outlook
9.9.5 Swot analysis
9.10 KeraMed Inc.
9.10.1 Business overview
9.10.2 Financial data
9.10.3 Product landscape
9.10.4 Strategic outlook
9.10.5 Swot analysis
9.11 AJL Ophthalmic SA
9.11.1 Business overview
9.11.2 Financial data
9.11.3 Product landscape
9.11.4 Strategic outlook
9.11.5 Swot analysis
9.12 Massachusetts Eye and Ear
9.12.1 Business overview
9.12.2 Financial data
9.12.3 Product landscape
9.12.4 Strategic outlook
9.12.5 Swot analysis
9.13 MEDIPHACOS
9.13.1 Business overview
9.13.2 Financial data
9.13.3 Product landscape
9.13.4 Strategic outlook
9.13.5 Swot analysis
9.14 MicroKpro
9.14.1 Business overview
9.14.2 Financial data
9.14.3 Product landscape
9.14.4 Strategic outlook
9.14.5 Swot analysis
